KRAS and lung cancer: In recent well-performed studies using targeted NGS, Vignot and co-workers found no discordance in driver mutations between primary lung cancers and their metastases, while Goswami and co-workers found a few cases of colonic cancer where a pathogenic KRAS mutation was not found in distant metastases [49, 50].